Beckley Psytech Limited, a UK private company dedicated to addressing neurological and psychiatric disorders through the novel application of psychedelic medicines, today announces that Cosmo Feilding
Beckley Psytech announces first cohort of psychotherapists have begun training for treatment resistant depression Phase 2 trials Training programme to be conducted in partnership with industry-leading educational company, FluenceInitiation of training represents key step to incorporate psychedelic-assisted psyc.
Beckley Psytech leads a new project focused on addressing psychiatric and neurological conditions through the use of psychedelic medicines. - News - PharmaTimes
Beckley Psytech, a privately owned, clinical stage, biotechnology company dedicated to addressing neuropsychiatric disorders through the novel application of psychedelic medicines, has today announced